Assessment of Two-Phase Diagnostic Timelines in Diabetic Retinopathy and Contributing Factors: A Cross-Sectional Analysis - Top-Institutions - MDSpire

Assessment of Two-Phase Diagnostic Timelines in Diabetic Retinopathy and Contributing Factors: A Cross-Sectional Analysis

  • By

  • Manling Lin

  • Guihua Zhang

  • Hanfu Wu

  • Yongqun Xiong

  • Xiaoling Xiao

  • Lixia Sun

  • Chuhua Zhang

  • March 14, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Wilmer Eye Institute, Johns Hopkins University
    Wilmer Eye Institute, Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Retinal Diseases
    • Diabetes-related Eye Disease

  • #2

    Massachusetts Eye and Ear Infirmary, Harvard Medical School
    Massachusetts Eye and Ear Infirmary, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Retina
    • Diabetic Eye Disease

  • #3

    Beijing Tongren Hospital, Capital Medical University
    Beijing Tongren Hospital, Capital Medical University

    Beijing, China

    Key Differentiators

    • Ophthalmology
    • Diabetic Retinopathy
    • Public Health

  • #4

    Moorfields Eye Hospital NHS Foundation Trust
    Moorfields Eye Hospital NHS Foundation Trust

    London, UK

    Key Differentiators

    • Ophthalmology
    • Retinal Diseases
    • Diabetic Retinopathy

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Endocrinology
    • Diabetic Retinopathy

Original Source(s)

Assessment of Two-Phase Diagnostic Timelines in Diabetic Retinopathy and Contributing Factors: A Cross-Sectional Analysis

  • by Manling Lin, Guihua Zhang, Hanfu Wu, Yongqun Xiong, Xiaoling Xiao, Lixia Sun, Chuhua Zhang

  • March 14, 2026

Related Content

Editorial: Addressing the Challenges of Diabetes Complications and Exploring Innovative Approaches

AI-driven saliency-guided retinal vessel segmentation framework for sustainable digital pathology

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

  • May 27, 2026

  • 3 min